Dr. Kathrin Mertens
Angestellt, Regional Clinical Trial Manager, Boehringer Ingelheim RCV GmbH & Co KG
Wien, Österreich
Werdegang
Berufserfahrung von Kathrin Mertens
Bis heute 5 Jahre und 1 Monat, seit Juni 2019
Regional Clinical Trial Manager
Boehringer Ingelheim RCV GmbH & Co KG8 Monate, Juli 2018 - Feb. 2019
Liaison Manager
CLINUVEL (UK) LTD
Involved in the controlled distribution of a first-in-class orphan drug, under strict conditions imposed by the EMA, as well as market access activities including pricing & reimbursement submissions.
3 Jahre und 2 Monate, Mai 2015 - Juni 2018
Clinical Trial Manager
Institute of Cancer Research
Main responsibility is the oversight and management of a number of multicentre phase II and III RCTs (radiotherapy and CTIMP), with some international collaborations and pharmacy collaboration.
7 Monate, Nov. 2014 - Mai 2015
Clinical Study Coordinator
Institute of Cancer Research
Responsible for the Quality of Life sub study of a trial with 100 centres and over 1,800 patients, and supporting trial manager with any tasks as required. Use of various trial management systems to oversee follow-up mailings, perform data checking to ensure high quality data collection, and to monitor return and compliance rates.
1 Jahr und 1 Monat, Okt. 2013 - Okt. 2014
Trial Manager
University of Abderdeen
Responsible for the oversight of musculoskeletal disorder multi centre RCT (over 500 patients), including liaison with study personnel at participating centres and reporting to relevant authorities and stakeholders. Use of database and trial administration systems to coordinate follow-up mailings, and overseeing data acquisition and data quality. Chair of the Epidemiology Procedures Group (SOP development and compliance monitoring).
Ausbildung von Kathrin Mertens
3 Jahre, Okt. 2010 - Sep. 2013
Biomedical Sciences
University of Aberdeen
“Zinc in inflammation and sepsis”: Investigating the effects of zinc deficiency on molecular mechanisms contributing to the pathophysiology of sepsis (in vitro and clinical pilot study).
Sprachen
Deutsch
Muttersprache
Englisch
Fließend